These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 186106
1. Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. Arai H, Sato Y. Biochim Biophys Acta; 1976 Oct 22; 444(3):765-82. PubMed ID: 186106 [Abstract] [Full Text] [Related]
4. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Sato Y, Izumiya K, Sato H, Cowell JL, Manclark CR. Infect Immun; 1981 Mar 22; 31(3):1223-31. PubMed ID: 6262248 [Abstract] [Full Text] [Related]
6. Immunologic and biochemical properties of the histamine-sensitizing factor from Bordetella pertussis. Lehrer SB, Vaughan JH, Tan EM. J Immunol; 1975 Jan 22; 114(1 Pt 1):34-9. PubMed ID: 46244 [Abstract] [Full Text] [Related]
7. Rapid purification of pertussis toxin (PT) and filamentous hemagglutinin (FHA) by cation-exchange chromatography. Ozcengiz E, Kilinç K, Büyüktanir O, Günalp A. Vaccine; 2004 Mar 29; 22(11-12):1570-5. PubMed ID: 15063583 [Abstract] [Full Text] [Related]
8. Partial purification and some properties of inhibitors to the hemagglutinating activity of leukocytosis-promoting factor (LPF) from Bordetella pertussis [proceedings]. Arai H, Sato U. Jpn J Med Sci Biol; 1978 Apr 29; 31(2):178. PubMed ID: 79665 [No Abstract] [Full Text] [Related]
9. Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties. Sato Y, Arai H, Suzuki K. Infect Immun; 1973 Jun 29; 7(6):992-9. PubMed ID: 4351972 [Abstract] [Full Text] [Related]
10. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers. Sato Y, Sato H. Tokai J Exp Clin Med; 1988 Jun 29; 13 Suppl():79-88. PubMed ID: 2908530 [Abstract] [Full Text] [Related]
11. Leucocytosis-promoting factor of Bordetella pertussis. I. Purification and characterization. Sato Y, Arai H. Infect Immun; 1972 Dec 29; 6(6):899-904. PubMed ID: 4344632 [Abstract] [Full Text] [Related]
14. Mutant of Bordetella pertussis which lacks ability to produce filamentous hemagglutinin. Watanabe M, Nakase Y. Infect Immun; 1982 Mar 29; 35(3):1018-23. PubMed ID: 6279510 [Abstract] [Full Text] [Related]
15. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough. Winsnes R, Lønnes T, Møgster B, Berdal BP. Dev Biol Stand; 1985 Mar 29; 61():353-65. PubMed ID: 2872124 [Abstract] [Full Text] [Related]
16. Purification and characterization of fimbriae isolated from Bordetella pertussis. Zhang JM, Cowell JL, Steven AC, Carter PH, McGrath PP, Manclark CR. Infect Immun; 1985 May 29; 48(2):422-7. PubMed ID: 2859248 [Abstract] [Full Text] [Related]
17. [The property of filamentous hemagglutinin of Bordetella pertussis]. Chow MP, Lin CK, Lin JS, Chau WK, Ho CH, Chen SY, Lee SH, Yung CH. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov 29; 24(4):331-8. PubMed ID: 1845342 [Abstract] [Full Text] [Related]
18. Purification and properties of Haemophilus paragallinarum hemagglutinin. Iritani Y, Katagiri K, Arita H. Am J Vet Res; 1980 Dec 29; 41(12):2114-8. PubMed ID: 7212446 [Abstract] [Full Text] [Related]
19. [Properties of an acellular preparation of Bordetella pertussis and its analysis after centrifugation in saccharose gradient]. Letowska I, Kaczurba E, Schiller B. Med Dosw Mikrobiol; 1993 Dec 29; 45(3):289-94. PubMed ID: 8189799 [Abstract] [Full Text] [Related]